The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Effect of Partial Ileal Bypass Surgery on Mortality and Morbidity from Coronary Heart Disease in Patients with Hypercholesterolemia: Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)
Open accessAbstract
BACKGROUND AND METHODS: The Program on the Surgical Control of the Hyperlipidemias (POSCH), a randomized clinical trial, was designed to test whether cholesterol lowering induced by the partial ileal bypass operation would favorably affect overall mortality or mortality due to coronary heart disease. The study population consisted of 838 patients (417 in the control group and 421 in the surgery group), both men (90.7 percent) and women, with an average age of 51 years, who had survived a first myocardial infarction. The mean follow-up period was 9.7 years. RESULTS: When compared with the control group at five years, the surgery group had a total plasma cholesterol level 23.3 percent lower (4.71 +/- 0.91 vs. 6.14 +/- 0.89 mmol per liter [mean +/- SD]; P less than 0.0001), a low-density lipoprotein cholesterol level 37.7 percent lower (2.68 +/- 0.78 vs. 4.30 +/- 0.89 mmol per liter; P less than 0.0001), and a high-density lipoprotein cholesterol level 4.3 percent higher (1.08 +/- 0.26 vs. 1.04 +/- 0.25 mmol per liter; P = 0.02). Overall mortality and mortality due to coronary heart disease were reduced, but not significantly so (deaths overall [control vs. surgery], 62 vs. 49, P = 0.164; deaths due to coronary disease, 44 vs. 32, P = 0.113). The overall mortality in the surgery subgroup with an ejection fraction greater than or equal to 50 percent was 36 percent lower (control vs. surgery, 39 vs. 24; P = 0.021). The value for two end points combined--death due to coronary heart disease and confirmed nonfatal myocardial infarction--was 35 percent lower in the surgery group (125 vs. 82 events; P less than 0.001). During follow-up, 137 control-group and 52 surgery-group patients underwent coronary-artery bypass grafting (P less than 0.0001). A comparison of base-line coronary arteriograms with those obtained at 3, 5, 7, and 10 years consistently showed less disease progression in the surgery group (P less than 0.001). The most common side effect of partial ileal bypass was diarrhea; others included occasional kidney stones, gallstones, and intestinal obstruction. CONCLUSIONS: Partial ileal bypass produces sustained improvement in the blood lipid patterns of patients who have had a myocardial infarction and reduces their subsequent morbidity due to coronary heart disease. The role of this procedure in the management of hypercholesterolemia remains to be determined. These results provide strong evidence supporting the beneficial effects of lipid modification in the reduction of atherosclerosis progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Specifically, each 1-mmol/L reduction in LDL-C was associated with an RR of 0.75 (95% CI, 0.66-0.86;P = .002)in major vascular events”
From Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis (2016) · cites this paper as [51]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Practical Nonparametric Statistics
Groggel, D. J., & Conover, W. J. (2000) · Technometrics · doi:10.2307/1271101 · Cited by 11,076
Immunochemical quantitation of antigens by single radial immunodiffusion
Mancini, G., Carbonara, A. O., & Heremans, J. F. (1965) · Immunochemistry · doi:10.1016/0019-2791(65)90004-2 · Cited by 9,091
Hubert, H. B., Feinleib, M., McNamara, P. M., & Castelli, W. P. (1983) · Circulation · doi:10.1161/01.cir.67.5.968 · Cited by 4,241
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
A Generalized Wilcoxon Test for Comparing Arbitrarily Singly-Censored Samples
Gehan, E. A. (1965) · Biometrika · doi:10.1093/biomet/52.1-2.203 · Cited by 3,407
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,512
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.220 · Cited by 2,294
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.
Kannel, W., Castelli, W., Gordon, T., & McNamara, P. M. (2020) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-1 · Cited by 2,160
Research works printed but not linked: 29
- 10.1001/jama.256.20.2823 · DOI · Paper page
- Leren, 1966, Acta Med Scand Suppl, 466, 1
- 1968, Lancet, 2, 693
- Frantz, 1975, Circulation, 52, II-4
- 10.1001/jama.231.4.360 · DOI
- 10.1001/jama.251.3.351 · DOI · Paper page
- 10.1001/jama.257.23.3233 · DOI
- Buchwald H. Intestinal bypass for hypercholesterolemia. In: Nyhus LM, Baker RJ, eds. Mastery of surgery. Vol. 3. Boston: Little, Brown, 1984:901–7.
- Buchwald H, Campos CT. Partial ileal bypass for control of hyperlipidemia and atherosclerosis. In: Sabiston DC Jr, Spencer FC, eds. Surgery of the chest. 5th ed. Philadelphia: W.B. Saunders, 1990:1799–819.
- Schouten, 1986, Artery, 13, 240
- 1959, Stat Bull Metrop Life Insur Co, 40, 1
- Bruce, 1971, Ann Clin Res, 3, 323
- National Heart and Lung Institute, Lipid Research Clinics Program. Manual of laboratory operations. Vol. 1. Bethesda, Md.: National Institutes of Health, 1974. (DHEW publication no. (NIH) 75–628.)
- 1970, Bull World Health Organ, 43, 891
- Mantel, 1966, Cancer Chemother Rep, 50, 163
- Matts, Controlled Clin Trials
- Campos, 1987, Surgery, 102, 424
- Campos, 1988, Curr Surg, 45, 380
- Campos, 1988, Surg Forum, 39, 193
- Addison, 1851, Guys Hosp Rep, 2, 267
- Ignatovski, 1908, Izviest Imp Voyenno-med Akad S Petersb, 16, 154
- Anitschkow, 1913, Centralbl Allg Pathol Pathol Anat, 24, 1
- Wacker, 1913, Münchener Med Wochenschr, 60, 2097
- European Coronary Surgery Study Group, 1982, Lancet, 2, 1173
- Buchwald, 1965, Surgery, 58, 22
- Scott, 1967, Surg Gynecol Obstet, 125, 3
- Buchwald, 1963, Circulation, 28, II-649
- Moore, 1969, Surgery, 65, 98
- Buchwald, Ann Surg
Cited by
Sorted by citations
Items 901–1,000 of 1,000
McGladdery, S. H. (2009) · cIRcle (University of British Columbia) · doi:10.14288/1.0089570
Atherosclerosis: A Life Changing Phenomenon
Rai, A. K., Chandra, S., Singh, S. P., & Parveen, A. (2016) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.51058
More on Partial Ileal Bypass Surgery for Hypercholesterolemia
Olson, R. E. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108083250616
Lepor, N. E., Contreras, L., Desai, C., & Kereiakes, D. J. (2015) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0773corr
Is cholesterol testing/treatment really beneficial?
dʼEmden, M. C. (1994) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1994.tb126631.x
Simvastatin with or without ezetimibe in familial hypercholesterolemia.
Clearfield, M. B. (2009) · PubMed
Pharmacological agents used in the treatment of cardiovascular disorders
Hawley, C. M., & Gibbs, H. H. (1993) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1993.tb138049.x
Clearfield, M. B. (2008) · Current Atherosclerosis Reports · doi:10.1007/s11883-009-0001-2
Must we Treat Uremic Dyslipidemia?
Beccari, M. (1993) · The International Journal of Artificial Organs · doi:10.1177/039139889301600502
Modell zum individualisierten Lipidmanagement
Weingärtner, O., Lütjohann, D., & Elsässer, A. (2016) · Der Kardiologe · doi:10.1007/s12181-016-0054-8
Molecular biological studies in atherothrombotic brain infarction
Mochizuki, R. A., Kataoka, S., Alam, R., Kasturi, R., & Yatsu, F. M. (1992) · Neurological Research · doi:10.1080/01616412.1992.11740049
Bariatric Surgery in Pediatric Weight Management
Dusad, A., Fernández, C. B., Rathore, G., Mittal, S. K., & Chatterjee, A. (2012) · CRC Press eBooks · doi:10.1201/b12261-72
Walcott, R., & Howard, W. J. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5223-4.00028-7
The POSCH Trial: Importance of Cholesterol Lowering in Reducing Coronary Heart Disease Progression
the POSCH Group, Campos, C. T., & Buchwald, H. (1995) · Medical science symposia series · doi:10.1007/978-94-011-0039-7_33
Self-citationMedical Treatment of Peripheral Arterial Disease
Gornik, H. L., & Creager, M. A. (2006) · Elsevier eBooks · doi:10.1016/b978-0-7216-0284-4.50024-5
Cholesterol-Lowering Coronary Angiography Trials: An Overview
Hirsch, L. J. (1995) · Medical science symposia series · doi:10.1007/978-94-011-0039-7_39
Plasma Cholesterol and Total Mortality
Paoletti, R., & Poli, A. (1995) · Medical science symposia series · doi:10.1007/978-94-011-0039-7_38
Angiographic Trials on Progression and Regression of Atherosclerosis by Plasma Lipid Reduction
Lewis, B. (1996) · Medical science symposia series · doi:10.1007/978-94-009-0311-1_14
From Bariatric surgery to Metabolic surgery
Caiazzo, R. J., Arnalsteen, L., & Pattou, F. N. (2010)
Summary How should future angiographic trials be designed
Bruschke, A. V. G., Jukema, J. W., & Reiber, J. H. C. (1998)
WOMEN SPECIFIC VARIABLES IN CARDIOVASCULAR DISEASES
Dodiya, Z. S., & Desai, R. N. (2017) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v7i2.1390
Pitt, B., & Furberg, C. D. (1994) · American Heart Journal · doi:10.1016/0002-8703(94)90250-x
Entwicklungsschwerpunkte der Rehabilitation in den 90ern
Mathes, P., & Mahler, H. (1991) · Steinkopff eBooks · doi:10.1007/978-3-642-53795-0_22
Surgical management of diabetes mellitus: future outlook
Sazhin, A. V., Khusyainova, A. I., & Petukhov, V. A. (2017) · Endoscopic Surgery · doi:10.17116/endoskop201723146-55
Preventie en behandeling van aandoeningen als gevolg van atherosclerose
Stalenhoef, A. F. H. (2008) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-6597-5_4
Review article Cardiovascular risk changes after lipid lowering medications: are they predictable?
Sirtori, C. R., Calabresi, L., Marchioli, R., & Bloomfield, H. E. (2000)
Progression and Regression of Atherosclerotic Coronary Artery Disease
East, C. A. (1992) · Baylor University Medical Center Proceedings · doi:10.1080/08998280.1992.11929777
Chihaoui, M., Sebai, I., Oueslati, I., Grira, W., Yazidi, M., Rissouli, C., Ftouhi, B., Ksantini, R., Chaker, F., & Slimane, H. (2018) · Nutrition Clinique et Métabolisme · doi:10.1016/j.nupar.2018.05.001
Kroon, A. A., & Stalenhoef, A. F. H. (1996) · Developments in cardiovascular medicine · doi:10.1007/978-94-009-0143-8_17
Statine bei instabiler Angina pectoris
Marschang, G., Kirchmair, R., & Patsch (1999) · Journal für Kardiologie (Krause & Pachernegg GmbH)
Statins and Reduction of Stroke: Cholesterol-Lowering versus Pleiotropic Effects
Caterina, R. D., Palma, F., & Napoli, P. D. (2004) · Elsevier eBooks · doi:10.1016/b978-0-7216-0380-3.50011-9
Coronary Atherosclerosis and Restenosis
Banai, S., Kurgan, A., & Gertz, S. D. (2001) · Elsevier eBooks · doi:10.1016/b978-012656975-9/50056-0
Cooperative Heart Disease Trials
Geller, N. L., & Friedman, L. M. (2005) · Encyclopedia of Biostatistics · doi:10.1002/0470011815.b2a17031
Surgical management of diabetes mellitus: future outlook (part 3)
Sazhin, A. V., Khusyainova, A. I., & Petukhov, V. A. (2017) · Endoscopic Surgery · doi:10.17116/endoskop201723354-64
Drugs for Treatment of Dyslipidemia Available in the USA
Streja, E., & Streja, D. A. (2019) · Springer eBooks · doi:10.1007/978-3-319-97765-2_13
CIRUGÍA BARIÁTRICA: UNA ACERTADA OPCIÓN TERAPÉUTICA
Menéndez, E. (2018) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v52i3.126
Minimal Access Bariatric Surgery
Mishra, R. (2008) · Jaypee Brothers Medical Publishers (P) Ltd. eBooks · doi:10.5005/jp/books/10948_37
The benefits of metabolic/bariatric surgery on diabetes mellitus
Buchwald, H., & Buchwald, J. N. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814831-0.00016-6
Self-citationDeterminants for Coronary Atherosclerosis Regression. The Marburg Lipid Intervention Trial
Stellwaag, M., Maisch, B., Strauer, B. E., Leschke, M., Schneider, J., Steinmetz, A., & Kaffarnik, H. (1993) · Recent developments in lipid and lipoprotein research · doi:10.1007/978-3-642-84855-1_25
Genetic disorders of lipoprotein metabolism
Bhatnagar, D., Schofield, J. D., & Soran, H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-809356-6.00014-9 · Cited by 1
Bruckert, É. (2019) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(19)30205-6
Schönfeld, P., & Meyer, F. P. (2020) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1071-8219
Participation in Clinical Trials as a Clinical Trialist for the Community Surgeon
Klein, J. D., & Carp, N. Z. (2020) · Success in academic surgery · doi:10.1007/978-3-030-35488-6_20
Steps Beyond Diet and Drug Therapy for Severe Hypercholesterolemia
Gordon, B. R., & Hudgins, L. C. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4557-0101-8.00027-8
Mechanical Surgery Eases the Burden of Metabolic Disease
MacGillivray, T. E. (2020) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2020.03.020
Metabolic (Not Mechanical) Surgery for Metabolic Diseases
Buchwald, H. (2020) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2019.12.045
Self-citationGotto, A. M., & Davidson, M. H. (2020) · Contemporary cardiology · doi:10.1007/978-3-030-56514-5_1
Keystones in hypercholesterolemia treatment epidemiology
Martinez, T. L. D. R. (2020) · International Journal of Family & Community Medicine · doi:10.15406/ijfcm.2020.04.00179
Corral, P., López, A. A. P., Giunta, G. A., Buitrago, A. F., & Saraiva, J. F. K. (2021) · doi:10.22541/au.161548923.32347892/v1
Editora, S. (2004)
Cardiometabolic Risk Reduction: A Review of Clinical Guidelines and the Role of SGLT-2 Inhibitors
Reid (2021) · The Journal of Family Practice · doi:10.12788/jfp.0216
Use of SGLT-2 Inhibitors in Patients with Chronic Kidney Disease
Mottl (2021) · The Journal of Family Practice · doi:10.12788/jfp.0225
Improving Shingles Vaccination Rates in Family Medicine
Luther (2021) · The Journal of Family Practice · doi:10.12788/jfp.0218
The Challenge: Finding the Most Appropriate Statin and Dose for Each Patient
Lillo (2021) · The Journal of Family Practice · doi:10.12788/jfp.0224
Cost-utility analysis of evolocumab in patients with ASCVD in Italy
Marcellusi, A., Bini, C., Rotundo, M. A., Arcangeli, E., Martínez, L., Vilela, F. S., & Mennini, F. S. (2021) · Global & Regional Health Technology Assessment · doi:10.33393/grhta.2021.2255
Gene therapy for the vulnerable plaque
Losordo, D. W., & Isner, J. M. (2008) · Springer eBooks · doi:10.1007/978-0-585-33754-8_40
Le, N., & Brown, W. V. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-878-6_28
Sierra, M. L. (2003) · Wiley eBooks · doi:10.1002/0471266949.bmc047
Lipoprotein Metabolism and the Treatment of Lipid Disorders
Freeman, M. W. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00042-3
Meinert, C. L. (2012) · Wiley eBooks · doi:10.1002/9781118315293.refs
Pedersen, T. R. (1999) · Contemporary cardiology · doi:10.1007/978-1-59259-731-4_23
(2002) · Circulation · doi:10.1161/circ.106.25.3373
Bestehorn, H.-P., & Roskamm, H. (1996) · Springer eBooks · doi:10.1007/978-3-642-97605-6_22
Fettstoffwechsel: Diagnostik und Therapie
Merkel, M. (2022) · Diabetologie und Stoffwechsel · doi:10.1055/a-1245-5169
Friedman, L. M., Furberg, C. D., & DeMets, D. L. (1998) · Springer eBooks · doi:10.1007/978-1-4757-2915-3_17
Regulation of intestinal bile acid transport in health and disease
Shneider, B. L. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6252-0_12
Schlienger, J.-L. (2015) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(15)30279-0
Buchwald, H. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-3106-2.00037-4
Self-citation(1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.6.662
Klinik der koronaren Herzerkrankung III: Der Herzinfarkt im chronischen Stadium
Roskamm, H., Bubenheimer, P., Frey, A., Meyer, K., & Schnellbacher, K. (1996) · Springer eBooks · doi:10.1007/978-3-642-97605-6_31
Pathophysiology of Vascular Disease
Zarins, C. K., & Glagov, S. (1999) · Springer eBooks · doi:10.1007/978-1-4757-3105-7_2
CrossRef Listing of Deleted DOIs
(2007) · CrossRef Listing of Deleted DOIs · doi:10.1007/s11932-004-0004-2
Cholesterol and its biological significance. Atherosclerosis. Statin therapy (Part 2)
Vasiliev, A. P., & Streltsova, N. N. (2022) · Сибирский журнал клинической и экспериментальной медицины · doi:10.29001/2073-8552-2022-37-2-13-20
The use of metabolic measurements in angiographic regression trials
Watts, G. F. (1996) · Developments in cardiovascular medicine · doi:10.1007/978-94-009-0143-8_3
Geschichte der Adipositaschirurgie in Deutschland
Weiner, R. A. (2022) · Springer eBooks · doi:10.1007/978-3-662-65556-6_1
Hypercholesterinämie – Wen, wann, wie behandeln?
Merkel, M. (2023) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-1956-9851
Angiographic Changes Associated with Dyslipidemia Therapy
Feeman, W. E. (2023) · Women Health Care and Issues · doi:10.31579/2642-9756/150
Foundations of Bariatric Surgery
Corpodean, F., Kachmar, M., Albaugh, V. L., & Schauer, P. R. (2024) · Springer eBooks · doi:10.1007/978-3-031-72309-4_2
Pedersen, T. R., & Tonstad, S. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-351-4_23
Clinical Effect of Evolocumab treatment in coronary artery bypass surgeryPreprint
Nasso, G., Santarpino, G., Vignaroli, W., Calabrese, V., Taverna, G., Rosa, I., Rosa, I., Bartolomucci, F., Montemurro, V., Mastroroberto, P., et al. (2025) · medRxiv · doi:10.1101/2025.03.20.25324358
Meyer, J., Bokisch, A., Darius, H., Heusch, G., Hort, W., Mohr-Kahaly, S., Rupprecht, H. J., & Voigtländer, T. (2000) · Springer eBooks · doi:10.1007/978-3-662-12156-6_17
de Feyter, P. J., Vos, J., Mario, C. D., Serruys, P. W. J. C., & Roelandt, J. R. T. C. (1994) · Developments in cardiovascular medicine · doi:10.1007/978-94-015-8358-9_34
Pharmacologic Agents in Preventive Cardiology
Militello, M. A., & Seo, T. H. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-001-8_13
Schuler, G. C., Hambrecht, R., Niebauer, J., & Schlierf, G. (1992) · Steinkopff eBooks · doi:10.1007/978-3-642-93676-0_12
Therapie mit CSE-Hemmern — mehr als Lipidsenkung?
Weizel, A. (1999) · Herz · doi:10.1007/bf03043817
Retardation and Regression of Coronary Atherosclerosis: Fact or Fiction?
Reís, S. E., & Gottlieb, S. O. (1992) · Medical science symposia series · doi:10.1007/978-94-011-2700-4_7
Hypocholesterolaemia in a child with familial hypercholesterolaemia
Weidinger, J., Conroy, C., Bell, D. A., & Martin, A. (2026) · BMJ Case Reports · doi:10.1136/bcr-2025-271433
Nasso, G., Marchese, A., Santarpino, G., Vignaroli, W., Calabrese, V., Taverna, G., Larosa, C., Bartolomucci, F., Fiore, F., Brigiani, M. S., et al. (2026) · JTCVS Open · doi:10.1016/j.xjon.2026.101684
Coronary Atherosclerosis: Chronic Coronary Syndromes
Gould, K. L. (2002) · Springer eBooks · doi:10.1007/978-3-642-56225-9_50
Kramsch, D. M. (1996) · Developments in cardiovascular medicine · doi:10.1007/978-94-009-0143-8_12
Lipid Metabolism and Menopause
Gotto, A. M., & Hoffman, A. S. (1994) · CPOBGYN. Clinical perspectives in obstetrics and gynecology · doi:10.1007/978-1-4612-4330-4_22
Pathogenesis of the Acute Coronary Syndromes: Hypotheses Generated from Clinical Experience
Bhalla, N. P., & Ambrose, J. (1997) · Springer eBooks · doi:10.1007/978-0-585-33754-8_12
Arterial Occlusive Diseases of the Extremities
Hirsch, A. T. (2003) · doi:10.1007/978-1-4757-4564-1_3
Approach to the Patient with Hyperlipidemia
Stone, N. J. (2001) · doi:10.1007/978-1-4615-6601-4_14
How should future angiographic trials be designed
Bruschke, A. V., Jukema, J., & Reiber, J. (1998) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-5123-8_9
Gleichmann, U., Mannebach, H., & Gleichmann, S. (1991) · Steinkopff eBooks · doi:10.1007/978-3-642-53795-0_7
Eandi, M. (2010) · Springer eBooks · doi:10.1007/978-1-4419-7222-4_19
Metadata
- Authors
- Buchwald, H., Varco, R. L., Matts, J. P., Long, J. M., Fitch, L. L., Campbell, G. S., Pearce, M. B., Yellin, A. E., Edmiston, W. A., Smink, R. D., Sawin, H. S., Campos, C. T., Hansen, B. J., Tuna, N., Karnegis, J. N., Sanmarco, M. E., Amplatz, K., Castaneda-Zuniga, W. R., Hunter, D. W., Bissett, J. K., Weber, F. J., Stevenson, J. W., Leon, A. S., & Chalmers, T. C.
- Affiliations
- University of Minnesota (US)
- University of Southern California (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1990-10-04
- Volume
- 323
- Issue
- 14
- Pages
- 946-955
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2331959986
- Cited by
- 1,001
- References
- 58
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 3 · 2023: 9 · 2022: 5 · 2021: 20 · 2020: 11 · 2019: 16 · 2018: 10 · 2017: 11 · 2016: 22 · 2015: 15 · 2014: 17 · 2013: 12 · 2012: 17
- FWCI
- 84.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Surgery › Cardiac and Coronary Surgery Techniques
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- partial ileal bypass, hypercholesterolemia, coronary artery disease, mortality, myocardial infarction, cholesterol lowering, LDL cholesterol, HDL cholesterol, first myocardial infarction, coronary artery bypass grafting, ejection fraction, long-term outcomes, nonfatal myocardial infarction
- MeSH terms
- Adult, Coronary Disease, Electrocardiography, Female, Follow-Up Studies, Humans, Hypercholesterolemia, Hyperlipidemias, Jejunoileal Bypass, Lipids, Male, Middle Aged, Ultrasonography, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Coronary Angiography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review